538 related articles for article (PubMed ID: 30428914)
21. MEN1 in children and adolescents: Data from patients of a regional referral center for hereditary endocrine tumors.
Vannucci L; Marini F; Giusti F; Ciuffi S; Tonelli F; Brandi ML
Endocrine; 2018 Feb; 59(2):438-448. PubMed ID: 28530019
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous lesions associated to multiple endocrine neoplasia syndrome type 1.
Vidal A; Iglesias MJ; Fernández B; Fonseca E; Cordido F
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):835-8. PubMed ID: 18435740
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1.
Marini F; Giusti F; Tonelli F; Brandi ML
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919851
[TBL] [Abstract][Full Text] [Related]
24. ARMC5 Alterations in Patients With Sporadic Neuroendocrine Tumors and Multiple Endocrine Neoplasia Type 1 (MEN1).
Damjanovic SS; Antic JA; Elezovic-Kovacevic VI; Dundjerovic DM; Milicevic IT; Beleslin-Cokic BB; Ilic BB; Rodic GS; Berthon A; Maria AG; Faucz FR; Stratakis CA
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4531-42. PubMed ID: 32901291
[TBL] [Abstract][Full Text] [Related]
25. Analysis of genotype-phenotype correlations and survival outcomes in patients with primary hyperparathyroidism caused by multiple endocrine neoplasia type 1: the experience at a single institution.
Horiuchi K; Okamoto T; Iihara M; Tsukada T
Surg Today; 2013 Aug; 43(8):894-9. PubMed ID: 23052745
[TBL] [Abstract][Full Text] [Related]
26. MEN1 clinical background.
Igaz P
Adv Exp Med Biol; 2009; 668():1-15. PubMed ID: 20175448
[TBL] [Abstract][Full Text] [Related]
27. A germline c.1546dupC MEN1 mutation in an MEN1 family: A case report.
Cho YY; Chung YJ
Medicine (Baltimore); 2021 Jun; 100(25):e26382. PubMed ID: 34160414
[TBL] [Abstract][Full Text] [Related]
28. Identification of MEN1 mutations in sporadic enteropancreatic neuroendocrine tumors by analysis of paraffin-embedded tissue.
Mailman MD; Muscarella P; Schirmer WJ; Ellison EC; O'Dorisio TM; Prior TW
Clin Chem; 1999 Jan; 45(1):29-34. PubMed ID: 9895334
[TBL] [Abstract][Full Text] [Related]
29. A novel deletion of the MEN1 gene in a large family of multiple endocrine neoplasia type 1 (MEN1) with aggressive phenotype.
Raef H; Zou M; Baitei EY; Al-Rijjal RA; Kaya N; Al-Hamed M; Monies D; Abu-Dheim NN; Al-Hindi H; Al-Ghamdi MH; Meyer BF; Shi Y
Clin Endocrinol (Oxf); 2011 Dec; 75(6):791-800. PubMed ID: 21627674
[TBL] [Abstract][Full Text] [Related]
30. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
Newey PJ; Jeyabalan J; Walls GV; Christie PT; Gleeson FV; Gould S; Johnson PR; Phillips RR; Ryan FJ; Shine B; Bowl MR; Thakker RV
J Clin Endocrinol Metab; 2009 Oct; 94(10):3640-6. PubMed ID: 19622622
[TBL] [Abstract][Full Text] [Related]
31. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
[TBL] [Abstract][Full Text] [Related]
32. UMD-MEN1 Database: An Overview of the 370 MEN1 Variants Present in 1676 Patients From the French Population.
Romanet P; Mohamed A; Giraud S; Odou MF; North MO; Pertuit M; Pasmant E; Coppin L; Guien C; Calender A; Borson-Chazot F; Béroud C; Goudet P; Barlier A
J Clin Endocrinol Metab; 2019 Mar; 104(3):753-764. PubMed ID: 30339208
[TBL] [Abstract][Full Text] [Related]
33. Germline MEN1 mutations in sixteen Japanese families with multiple endocrine neoplasia type 1 (MEN1).
Hai N; Aoki N; Matsuda A; Mori T; Kosugi S
Eur J Endocrinol; 1999 Nov; 141(5):475-80. PubMed ID: 10576763
[TBL] [Abstract][Full Text] [Related]
34. Genotype-phenotype analysis in multiple endocrine neoplasia type 1.
Kouvaraki MA; Lee JE; Shapiro SE; Gagel RF; Sherman SI; Sellin RV; Cote GJ; Evans DB
Arch Surg; 2002 Jun; 137(6):641-7. PubMed ID: 12049533
[TBL] [Abstract][Full Text] [Related]
35. Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome.
Donati S; Ciuffi S; Marini F; Palmini G; Miglietta F; Aurilia C; Brandi ML
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066578
[TBL] [Abstract][Full Text] [Related]
36. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic features of patients with multiple endocrine tumors who have neither family history nor MEN1 germline mutations.
Sakurai A; Katai M; Yumita W; Minemura K; Hashizume K
Endocrine; 2004 Feb; 23(1):45-9. PubMed ID: 15034196
[TBL] [Abstract][Full Text] [Related]
39. A novel germline mutation of multiple endocrine neoplasia type 1 (MEN1) gene in a Japanese MEN1 patient and her daughter.
Ohye H; Sato M; Matsubara S; Miyauchi A; Kishi-Imai K; Murao K; Takahara J
Endocr J; 1999 Apr; 46(2):325-9. PubMed ID: 10460018
[TBL] [Abstract][Full Text] [Related]
40. Management impact: effects on quality of life and prognosis in MEN1.
Marini F; Giusti F; Tonelli F; Brandi ML
Endocr Relat Cancer; 2017 Oct; 24(10):T227-T242. PubMed ID: 28733468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
